A Feasibility Study to Evaluate the Effect of Concomitant Renal Denervation and Cardiac Ablation on AF Recurrence

NACompletedINTERVENTIONAL
Enrollment

61

Participants

Timeline

Start Date

April 15, 2014

Primary Completion Date

October 15, 2018

Study Completion Date

October 15, 2018

Conditions
Persistent Atrial FibrillationParoxysmal Atrial FibrillationHypertension
Interventions
DEVICE

Renal Artery Ablation

Renal artery denervation using the EnligHTN™ Renal Denervation System

DEVICE

Cardiac Ablation

Safire BLU™ Duo or Therapy Cool Path Duo Irrigated Ablation Catheter or Therapy Cool Flex Irrigated Ablation Catheter EnSite Velocity System Agilis NxT Guiding Introducer

Trial Locations (2)

01307

Herzzentrum Dresden GmbH Universitätsklinik, Dresden

04289

Herzzentrum Leipzig GmbH, Leipzig

Sponsors
All Listed Sponsors
lead

Abbott Medical Devices

INDUSTRY